Category: Providence Medical Technology
Providence Medical Technology Raises $12 Million Through a Combination of Equity and Debt Financing
Company Also Announces Appointment of Jason Hoffman as Vice President of Global Sales
LAFAYETTE, Calif. — August 26, 2015 — Providence Medical Technology, Inc., an innovator in tissue-sparing cervical spine technology, today announced the closing of $12 million in new financing for the company. The proceeds will be used to further commercialize and expand its portfolio of DTRAX® cervical fusion products designed to help patients suffering from cervical degenerative disc disease.
Providence Medical Technology Launches DTRAX® Bone Screws to U.S. Market
New Bone Screws to Provide Supplemental Fixation for Joint Fusion
Lafayette, CA (May 29, 2015) ‐‐ Providence Medical Technology, Inc. today announced the full commercial launch of DTRAX Bone Screws in the U.S. market.
“This release represents an important step in broadening our platform of innovative, single-use instruments and implants for cervical fusion,” commented Jeff Smith, Chief Executive Officer of Providence Medical Technology. “Cervical fusion and indirect decompression with DTRAX products offers a compelling, tissue-sparing option for patients suffering from cervical radiculopathy.” Continue Reading
Providence Medical Technology Granted CE Mark For Full DTRAX Line of Cervical Spine Products
Providence Medical Technology Granted CE Mark For Full DTRAX Line of Cervical Spine Products Approval Expected to Fuel Growth in EU Market
February 25, 2015 03:00 AM Eastern Daylight Time
LAFAYETTE, Calif. — Providence Medical Technology, Inc. announced today it has obtained a CE Mark for its DTRAX Spinal System, DTRAX Cervical Cage, and DTRAX Bone Screw. This regulatory approval expands the company’s international product offering to include its entire DTRAX portfolio. Continue Reading
Providence Medical Technology Announces Expansion of Patent Portfolio
Three Additional Patents Issued Protecting DTRAX Platform for Cervical Fusion
LAFAYETTE, Calif. — (BUSINESS WIRE) — Providence Medical Technology, Inc. today announced that the U.S. Patent and Trademark Office issued patents 8,834,530, Cervical Distraction Method; 8,834,472, Vertebral Joint Implants and Delivery Tools, and 8,828,062, Vertebral Joint Implants and Delivery Tools to the company in September 2014
MedVest Fund One Invests in Providence Medical Technology
Jupiter, Florida – Stanmore Medical Investments is pleased to announce that MedVest Fund One has invested into Bay Area based Providence Medical Technology. MedVest Fund One’s investment will support Providence’s U.S. launch of its full DTRAX product portfolio. .
- ‹ Previous
- 1
- 2